Streetwise Reports (@swreports) 's Twitter Profile
Streetwise Reports

@swreports

Streetwise Reports is the leading source of news & investing ideas in gold, precious metals, mining, energy, renewables, biotech, life sciences & technology.

ID: 582355251

linkhttp://www.streetwisereports.com calendar_today16-05-2012 23:55:13

11,11K Tweet

6,6K Followers

1,1K Following

Streetwise Reports (@swreports) 's Twitter Profile Photo
Streetwise Reports
@swreports

24 days ago

Biotech Enters Agreement with Co. Behind Tegoprubart ow.ly/kQuu50WpyHs Sernova Biotherapeutics Inc. likely will use this new monoclonal antibody as an immunosuppressant in its Phase 1/2 trial's Cohort C instead of previously used tacrolimus, noted an H.C. Wainwright & Co.